Challenges and development opportunities facing China's in vitro diagnostic industry

Release date: 2008-08-21

China's in vitro diagnostic industry development history The in vitro diagnostic industry is an integral part of the medical device and pharmaceutical industry. The Chinese in vitro diagnostic industry is an emerging industry with a development history of about 20 years. It is a spontaneously formed and growing industry. In vitro diagnosis refers to the detection of a sample (blood, body fluid, tissue, etc.) from the human body for diagnosis, as opposed to in vivo diagnosis. The instruments and reagents are required for the detection process, and these instruments and reagents constitute an in vitro diagnostic system. The companies engaged in the research, development, production and marketing of these instruments and reagents form the in vitro diagnostic industry. It brings together technologies related to biology, medicine, electronics, and machinery. In vitro diagnostic products can be divided into several major categories according to the testing items of laboratory medicine: biochemistry, immunity, blood and clinical examination, microbiology, molecular diagnosis and so on. The in vitro diagnostic industry has also grown with the continuous development of the medical industry. Since the mid-1980s, some foreign-funded and private enterprises have begun to develop and produce corresponding products. Some state-owned units have produced some products, but there is no large-scale government-led and investment, and there is no corresponding industrial policy. The products at that time were mainly based on detection reagents, and some semi-automatic small instruments. With the development of 20 years, China's in vitro diagnostic industry has undergone tremendous development and changes. At present, China's in vitro diagnostic products have included several major categories in this field, and from reagents to instruments to the entire detection system (instruments) Integration with reagents; from manual semi-automatic systems to fully automated systems; from domestic markets to foreign markets; from simple imitation to independent innovation. Moreover, the products are constantly being improved and developed, and the scale of the company is gradually expanding. This industry is still mainly private and foreign-funded enterprises, forming a multi-billion-dollar industry and filling many gaps in China. At the same time, the government's laws and regulations are constantly being established and improved, from the original disorder to the gradual standardization; the government has also introduced some policies to support and encourage industrial policies. The in vitro diagnostic industry presents a constantly evolving situation and trend. Second, China's in vitro diagnostic industry faces great development opportunities in the future China's medical market continues to develop China's medical market will have greater development with the deepening of medical reform, and it will also bring many opportunities to the in vitro diagnostic industry. The ever-expanding medical needs will require more tests; the improvement of health requires more home diagnostic products; new clinical problems and personalized treatments need to be supported by new in vitro diagnostic techniques; the establishment of basic medical systems And expansion requires technologies and products that are suitable for this market; new pathogens that arise from environmental and ecological changes require new diagnostic techniques and products, and so on. These will bring a lot of room for development and opportunities for this industry. Diversification and expansion of foreign market demand With the development of domestic products in recent years, we have many products that have formed certain advantages and opportunities in the international market. The advantages of Chinese manufacturing are well in some areas of the in vitro diagnostic industry. In the meantime, while promoting products to the international market, it will also stimulate Chinese companies to develop more products and enter more markets. Let domestic and foreign markets develop together. The continuous development of inspection technology With the development of science and technology, the field of in-vitro diagnosis will continue to have new inventions and new creations, which will bring new markets. Compared with other fields, biotechnology is a field in which Chinese people invent and create more, and China has a large population, and various diseases and problems have manifested. This has enabled Chinese people to develop technologies and products in this field with certain resources and characteristics. The equipment and pharmaceutical industries are most likely to have areas of internationally advanced technology and products. III. Problems and Challenges Faced by the In Vitro Diagnostic Industry: China's in vitro diagnostic industry is still weak. The global in vitro diagnostic industry is at US$37 billion, and China accounts for 2-3%. Nearly 70% of the products in this 2-% are imported products, and the products that are truly manufactured by China itself are still small, and there are fewer independent original products, not to mention that many are produced by Sino-foreign joint ventures. product. As a whole, the enterprises in the industry are still small, small in scale and relatively scattered. They are usually single-domain or single-technology and product-oriented enterprises. There are still fewer enterprises with multi-domain technologies and products and system products. Fewer businesses. The continuous establishment and improvement of the policy In recent years, the government has done a lot of efforts and work in the policy, and formed a series of laws and regulations to play a positive role in guiding the development of the industry. At the same time, what is of concern is how to adapt these laws and regulations to the current development of the industry. There is still a lot of work to be done. It is not the more advanced, the better it is in line with international standards. After all, China’s 30 years of reform and opening up is also a process of gradual and continuous development. It is difficult to expect to improve in many areas and be consistent with the advanced level of foreign countries. Otherwise, China's in vitro diagnostics industry will not be able to grow from scratch, grow from small to large, and continue to develop. Moreover, even if developed countries still have a lot of different opinions and interests in this field, simply saying that they will be in line with international standards will bring them into trouble. Which country or region is it in line with? Therefore, the formulation of policies is not only to regulate the industry, but more importantly to encourage and guide the development of the industry, because the industry does not need to manage. The control of medical expenses With the continuous deepening of medical reform, the medical expenses will also be continuously controlled in an overall manner, which will inevitably affect the inspection fees, and the inspection costs will continue to decline. This inevitably affects the use of inspection products, especially the use of new technologies and new products. How to develop and produce products of good quality and low price is a challenge that domestic local enterprises continue to face. The management of the enterprise itself is still not perfect Compared with other industries, the in vitro diagnostic industry has a short history, and there are still many places in management and operation that need to be improved. Whether it is strategic positioning, technology and product development, production operation management, marketing promotion, talent management, standardized management, etc., it is necessary to intensify improvement and improvement. Since the development of the in vitro diagnostic industry is often started by a technology, a product, and a market segment, entrepreneurs are often experts in a certain field or aspect, which is also the original driving force for enterprise development. However, when enterprises continue to develop and continue to enter new technologies, new products, and new markets, entrepreneurs may find it difficult to become an expert in every field. At this time, the original management operation may not be sufficient, and the bottleneck of development and expansion will come out. It is. IV. Countermeasures for the in vitro diagnostic industry Although there are still many difficulties and problems in the in vitro diagnostic industry, we have many development opportunities and bright prospects. There are many difficulties and challenges in actively strengthening self-construction. First of all, enterprises within the industry must actively work hard to continuously adjust and continuously strengthen their own management. Can not wait for the environment to become better, policy support, and only through their own efforts can make the environment better, market recognition, will get more policy support. The government actively encourages and supports the in vitro diagnostic industry. Although the in vitro diagnostic industry is still weak and small, it faces a lot of development space and opportunities, and it needs the active encouragement and support of the government. The formulation of industrial policies and the formulation of laws and regulations must not only see the level of international development, but also the reality of domestic development, including the reality of China's economic development, the reality of China's medical institutions, the reality of in vitro diagnostic industries, and the reality of government operations and management. Sometimes it is not as advanced as possible, but it should be the best. Promoting industry development in a variety of ways Due to the diversity of in vitro diagnostic technologies and products, and the breadth of the market, it is difficult for a company to do anything and do everything well. Therefore, it is necessary not only to strengthen independent research and development, but also to rely on various joint development paths, joint research and development, cooperative production, common market promotion, industrial integration and so on. Moreover, the development of China's capital market also provides a good opportunity and platform for the development of in vitro diagnostic industry. As an emerging industry, we firmly believe that as long as the companies in the industry work hard first and with the support of the government, the in vitro diagnostic industry will be able to develop into an internationally competitive industry for the development of China's medical industry and to promote China and international inspections. A unique contribution is made to the improvement of the medical level.

Source: Fosun Diagnosis Zhu Yaoyi